Sun Pharma to buy Ranbaxy for $3.2 billion
India | News | By BioSpectrum Bureau | 0 Comment | 07 Apr, 2014
Singapore: Paving way for a historical deal in the Indian pharma industry, Indian drug major Sun Pharmaceutical industri...Read more
India | News | By BioSpectrum Bureau | 0 Comment | 07 Apr, 2014
Singapore: India based generics firm Sun Pharmaceutical Industries has announced to acquire Ranbaxy Laboratories through...Read more
Scientists sequence mitogenome of core crop pest
India | News | By BioSpectrum Bureau | 0 Comment | 07 Apr, 2014
Singapore: Phytophagous ladybird beetle, Henosepilachna pusillanima (Mulsant), synonym of Epilachnadodecastigma (Wiedema...Read more
Dr. Reddy's launches generic of Boniva
India | News | By BioSpectrum Bureau | 0 Comment | 02 Jul, 2012
Bangalore: Dr. Reddy's Laboratories has launched Ibandronate sodium tablets (150 mg), a bioequivalent generic version of...Read more
Challenge No 6: Regulatory hurdles
India | Analysis | By BioSpectrum Bureau | 0 Comment | 17 May, 2012
The regulatory environment for life sciences companies is known for its challenging nature. The framework is confusing a...Read more
India | News | By BioSpectrum Bureau | 0 Comment | 29 May, 2014
Bangalore: MERS scare swirls up in India, as Karnataka health officials and health minister Mr U T Khader confirmed a su...Read more
GE to invest $120 mn to improve cancer care in India
India | News | By BioSpectrum Bureau | 0 Comment | 03 Apr, 2014
Singapore: The centers will offer latest technology for diagnosing and treating cancer, and will follow the same standar...Read more
Lupin acquires Mexican firm Laboratorios Grin
India | News | By BioSpectrum Bureau | 0 Comment | 31 Mar, 2014
Singapore: Foraying into South American pharmaceutical market, India based Lupin Pharmaceutical has acquired Mexico firm...Read more
Asia pharma industry to touch $386 bn:Report
India | Analysis | By BioSpectrum Bureau | 2 Comment | 05 Dec, 2013
Singapore: As Asia emerges as a major engine of global economic growth, the pharmaceutical and biotechnology industries ...Read more
Healthcare equity investment grows by 125% in APAC, declines in west
India | News | By BioSpectrum Bureau | 0 Comment | 28 Mar, 2014
Singapore: As the global investment community continues its recovery from the 2008 financial crisis, the total value of ...Read more
India | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2014
Singapore: As MERS is multiplying incessantly, authorities in Indian state Andhra Pradesh, have issued an advisory to tr...Read more
Indian drug makers get 15 days on price revision
India | News | By BioSpectrum Bureau | 0 Comment | 01 Oct, 2013
New Delhi: In a bid to move towards strict enforcement of the new drug pricing policy in India, the country's National P...Read more
Should we trust the credit ratings?
India | Influencers | By BioSpectrum Bureau | 0 Comment | 07 Sep, 2012
Political events in India and the government's lack of conviction on policy matters have taken their toll on India's ima...Read more
ASSOCHAM pushes for market-based drug pricing in India
India | Opinion | By BioSpectrum Bureau | 0 Comment | 21 Nov, 2012
Bangalore: The Associated Chambers of Commerce and Industry of India (ASSOCHAM) apprehends that the Supreme Court rulin...Read more
Mylan buys Strides Acrolab's Agila for $1.6 bn cash
India | News | By BioSpectrum Bureau | 0 Comment | 28 Feb, 2013
Bangalore: Mylan has signed a definitive agreement with Strides Arcolab to acquire its generic injectable products unit,...Read more
Let's make India known for innovations'
India | Opinion | By BioSpectrum Bureau | 0 Comment | 25 Mar, 2014
As a scientist-turned entrepreneur, my journey has taken a long time, with many struggles along the way. For an entrepre...Read more
"Import duty on medical instruments must be reduced"
India | Influencers | By BioSpectrum Bureau | 1 Comment | 02 Apr, 2014
Singapore: Mr Saurabh Gupta, Principal Consultant, Healthcare Advisory Services at PricewaterhouseCoopers India speaks t...Read more
What are angel investors looking for?
India | Influencers | By BioSpectrum Bureau | 0 Comment | 03 Sep, 2012
Healthcare, biotech, pharma and life sciences are sectors that involve patient bunch of people who are willing to wait f...Read more